about
Interferon (IFN) and Cellular Immune Response Evoked in RNA-Pattern Sensing During Infection with Hepatitis C Virus (HCV)Viruses and human cancers: a long road of discovery of molecular paradigms.The tripartite virions of the brome mosaic virus have distinct physical properties that affect the timing of the infection process.Natural killer cell function and dysfunction in hepatitis C virus infection.The Strange, Expanding World of Animal Hepaciviruses.An interferon response gene signature is associated with the therapeutic response of hepatitis C patientsImmune control and failure in HCV infection--tipping the balance.Functionally conserved architecture of hepatitis C virus RNA genomes.Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?Antiviral interferon-beta signaling induced by designed transcription activator-like effectors (TALE).Impairment of type I but not type III IFN signaling by hepatitis C virus infection influences antiviral responses in primary human hepatocytesIntrinsic Viral Factors Are the Dominant Determinants of the Hepatitis C Virus Response to Interferon Alpha Treatment in Chimeric Mice.Transcriptional Dysregulation of Upstream Signaling of IFN Pathway in Chronic HCV Type 4 Induced Liver Fibrosis.How do persistent infections with hepatitis C virus cause liver cancer?Permissivity of primary hepatocytes and hepatoma cell lines to support hepatitis C virus infection.Emerging roles of interferon-stimulated genes in the innate immune response to hepatitis C virus infectionImmunity and hepatitis C: a review.Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients.Sustained hyperresponsiveness of dendritic cells is associated with spontaneous resolution of acute hepatitis C.The Molecular Chaperone GRP78 Contributes to Toll-like Receptor 3-mediated Innate Immune Response to Hepatitis C Virus in Hepatocytes.Ever closer to a prophylactic vaccine for HCV.ISG12a Restricts Hepatitis C Virus Infection through the Ubiquitination-Dependent Degradation Pathway.Viral genome imaging of hepatitis C virus to probe heterogeneous viral infection and responses to antiviral therapies.Hepatitis C, innate immunity and alcohol: friends or foes?Progress in the development of vaccines for hepatitis C virus infection.Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons.Acetaldehyde accelerates HCV-induced impairment of innate immunity by suppressing methylation reactions in liver cells.Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response to therapy.Dual Roles of Two Isoforms of Autophagy-related Gene ATG10 in HCV-Subgenomic replicon Mediated Autophagy Flux and Innate Immunity.Viral persistence, liver disease and host response in Hepatitis C-like virus rat model.Chronic Hepatitis C Virus Infection and the Proinflammatory Effects of Injection Drug Use.Innate and Adaptive Immune Responses in Chronic HCV Infection.The 5BSL3.2 Functional RNA Domain Connects Distant Regions in the Hepatitis C Virus Genome.Characterizing hepatitis C virus epidemiology in Egypt: systematic reviews, meta-analyses, and meta-regressions.Hepatitis C virus NS4B induces the degradation of TRIF to inhibit TLR3-mediated interferon signaling pathway.TRIM21 Promotes Innate Immune Response to RNA Viral Infection through Lys27-linked Polyubiquitination of MAVS.
P2860
Q26778005-F207ED09-4B7B-4139-B3B8-A236A7F8614BQ30384388-8199B31F-65E9-4ED9-8BA4-67F264E6A82EQ33887723-6A847AC1-2EA3-4ACD-82D2-DDA9B09A8C0BQ33892695-12F611A4-913B-4C55-B8DD-782B14E61123Q33924522-C8E4C544-B3C3-41A0-8D27-F87AB37482B7Q34027569-8E43F42A-52CF-42AD-8B0F-9DF06951C3E3Q34178628-7F1A0F0E-0643-4248-AD95-52E2389B5A5AQ35229364-6660C4AC-EF3B-4FDA-BC67-6242CB7262CFQ35270150-19D4E50D-FF37-42DA-8AE1-61AF7BA1DA50Q35484998-67C8801B-7AAE-470F-AB2C-EAABC10F7083Q35590991-CDFD3AB5-3066-4C2A-88E9-B26A3FF63666Q35893868-EEC61A9F-E028-4311-9ECD-DE72494933E9Q36004897-77608A8B-D45A-46FB-A63F-11BFAC8DEDBCQ36236839-1A693F9F-6FAC-4C26-9EB5-F1FCBCEC3993Q36255092-DF14285E-5C35-46EE-A42C-B1FB6AF892E9Q36460968-9C6A11B7-154B-4900-806E-E83CA3D6E61DQ36594965-E5CD9063-7968-4AE8-963D-45ED4889DB4DQ36741778-625E541E-3F1D-4D16-B203-097364ACEF08Q36911650-EB4DE558-F48C-4B41-906C-5B23930784D2Q37066043-D3AC0534-E1DE-4D19-B9E7-4A263B0DBF60Q37089122-37F2A44E-31FC-44F1-8B3A-B98C86B9F4F5Q37093500-31D7339B-3426-45E5-828D-2D1D4104ED38Q37721750-9134D980-FAD3-4F3E-B774-961B7D3243A1Q38349031-FEF6ECFF-B9AC-4355-B60D-9EB0724CAC66Q38635596-D0087CB7-DE59-423F-8CF0-6EAA49337165Q38705509-056DFB6F-8D2F-47F5-8CB3-FC36A3927992Q38845625-ECD64DD7-2394-4F38-86CB-5C0FD1EA6808Q38945754-EB773F5A-C764-41C0-80D7-9CEB6E6504F6Q40044595-7284E7BF-C961-4624-A464-47B906B7BEB0Q40062848-444C418A-965D-40A9-9625-0689C3A5FBD8Q40577279-00E00907-19E5-49BB-8E9B-017F6C1081F6Q41035955-968C8528-DDB9-4F44-9632-10569FE1A931Q44757794-429650E9-22EC-4BD1-989F-AB8771D5A5C4Q47548612-C293F9B7-4434-4A35-AC8E-91A8AB6DEDA4Q54204350-121E234D-6278-46D9-AE9F-C64AC9D5D3C6Q54216824-DB9A05FE-2396-4573-84EC-91489DB091F9
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Innate immune responses in hepatitis C virus infection
@ast
Innate immune responses in hepatitis C virus infection
@en
Innate immune responses in hepatitis C virus infection
@nl
type
label
Innate immune responses in hepatitis C virus infection
@ast
Innate immune responses in hepatitis C virus infection
@en
Innate immune responses in hepatitis C virus infection
@nl
prefLabel
Innate immune responses in hepatitis C virus infection
@ast
Innate immune responses in hepatitis C virus infection
@en
Innate immune responses in hepatitis C virus infection
@nl
P2860
P3181
P1476
Innate immune responses in hepatitis C virus infection
@en
P2093
Stanley M. Lemon
P2860
P2888
P3181
P356
10.1007/S00281-012-0332-X
P407
P577
2013-01-01T00:00:00Z
P5875
P6179
1019201612